Apollo Hospitals announces Q2 & H1FY19 results

New Delhi, November 24, 2018: Launched the first-ever AI-powered Cardiovascular Disease Risk Score API (Application Program Interface), designed specifically to predict risk of Cardiovascular Disease in the Indian population

Became the most awarded hospital group in Asia for the fifth successive year with 11 awards at Hospital Management Asia (HMA) 2018

Apollo Hospitals Chennai – flagship facility of the group and the country’s first corporate hospital, marked its 35th anniversary in September 2018

Standalone Pharmacy business being reorganized for a potential value discovery at a later stage

H1FY19 Standalone Revenues up 16% at Rs. 4,001 crores EBITDA at Rs. 484 crores, higher by 23% yoy PAT grew 31% yoy to Rs. 139 crores

Q2FY19 Standalone Revenues up 15% at Rs. 2,090 crores EBITDA at Rs. 258 crores, higher by 17% yoy PAT grows 11% yoy to Rs. 79 crores

Healthcare services reported 11% revenue growth in Q2 FY19 aided by 9% growth at Mature Hospitals and 23% growth in new hospitals

SAP reported 20% growth in Revenues in Q2 FY19 EBITDA grew by 42%, EBITDA margins at 5.3% in Q2 FY19 Net addition of 82 stores in Q2FY19 Pan-India network now at 3,167 stores Readmore

Corporate Comm India(CCI Newswire)